First Aid Antifungal Medicated
NDC 75983-002
Product Information
First Aid Antifungal Medicated is a OTC MONOGRAPH FINAL-approved product labeled by First Aid Research Corp.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a white product. This product entry covers the primary NDC 75983-002 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 75983-002?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- TOLNAFTATE (UNII: 06KB629TKV)
- TOLNAFTATE (UNII: 06KB629TKV) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- PETROLATUM (UNII: 4T6H12BN9U)
- CETYL ALCOHOL (UNII: 936JST6JCN)
- MINERAL OIL (UNII: T5L8T28FGP)
- METHYLPARABEN (UNII: A2I8C7HI9T)
- POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- PROPYLPARABEN (UNII: Z8IX2SC1OH)
- WATER (UNII: 059QF0KO0R)
- SORBITAN MONOSTEARATE (UNII: NVZ4I0H58X)
- STEARYL ALCOHOL (UNII: 2KR89I4H1Y)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 103951 - tolnaftate 1 % Topical Cream
- RxCUI: 103951 - tolnaftate 10 MG/ML Topical Cream
* Please review the full disclaimer at the bottom of this page.
Patient Education
Tolnaftate
Tolnaftate stops the growth of fungi that cause skin infections, including athlete's foot, jock itch, and ringworm. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
[Learn More]
* Please review the full disclaimer at the bottom of this page.